After several subdued years, M&A activity in the life sciences sector has rebounded strongly in 2026. With major pharma companies facing...
An overview of the OSA, covering its scope, key obligations and what organisations need to navigate the evolving regulatory landscape.
Read more about The Safety Net →
Evolving consumer, advertising and competition requirements, and how organisations can prepare for increased enforcement and compliance demands.
Read more about The UK’s consumer law regime (DMCC) →
We advise companies in the women's health sector on the commercial, legal and regulatory challenges of bringing new therapies and solutions to market, helping to address the gender health gap.
Read more about Women's health and innovation →/Passle/5f3d6e345354880e28b1fb63/MediaLibrary/Images/2026-10-14-13-50-16-944-6acf8898a81c552c14eaf07b.jpg)